CYTO.V Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 15, 2025
Report Source: 2025 1st Quarter Report
C
Cytophage Technologies Ltd. Stock Analysis CYTO.V
Cytophage Technologies Ltd. is a pioneering biotechnology company, which engages in bacteriophage research, product development, and commercialization. The firm's business activity is to develop bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and treatment. Bacteriophages are viruses that only infect and kill bacteria. These natural killers of bacteria can overcome cellular or organism-level defenses. The firm is using de-risked and patented technology to advance products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is a poultry health product offered by the Company.
Read More Cytophage Technologies Ltd (CYTO.V) Chart
Key Statistics of Cytophage Technologies Ltd (CYTO.V)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.03Volume
24.71KP/E Ratio (TTM)
-52 Week Range
Market Cap
2.71MAvg. Volume
185.41KDividend Yield
-Financial Metrics & Statements of Cytophage Technologies Ltd (CYTO.V)
FAQ's for Cytophage Technologies Ltd (CYTO.V)
- According to Musaffa’s Shariah screening methodology, Cytophage Technologies Ltd (CYTO.V) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.